Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults
在加纳健康成年人中开展的 1b 期临床试验中,研究人员评估了 INO-4500(一种合成 DNA 疫苗,用于预防拉沙病毒)的安全性、耐受性和免疫原性。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1658549
Koram, Kwadwo Ansah; Walker, Kathleen A; Orizu, Bonaventure; Marrero, Idania; Boyer, Jean; Yang, ShuPing; Broderick, Kate E; Kusi, Kwadwo Asamoah; Kyei-Baafour, Eric; Ofori, Ebenezer Addo; Pobee, Abigail; Adu-Amankwah, Susan; Amoakoh-Coleman, Mary; Amoakoh, Hannah Brown; Abuaku, Benjamin; Badji, Edem; Ntiri, Michael; Quaye, Lydia; Morrow, Matthew P; Sylvester, Albert J; Reuschel, Emma L; Gillespie, Elisabeth; Liebowitz, David; Humeau, Laurent M